Vimal Mehta
CEO
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioXcel Therapeutics, Inc. (BTAI) | Chief Executive Officer | $1,001,570 | $1,119,245 |
| 2023 | BioXcel Therapeutics, Inc. (BTAI) | Chief Executive Officer | $1,001,569 | $4,731,147 |
| 2022 | BioXcel Therapeutics, Inc. (BTAI) | Chief Executive Officer | $944,436 | $4,559,195 |
| 2021 | BioXcel Therapeutics, Inc. (BTAI) | Chief Executive Officer | $916,701 | $9,372,177 |
| 2020 | BioXcel Therapeutics, Inc. (BTAI) | Chief Executive Officer and President | $890,000 | $9,576,550 |
| 2019 | BioXcel Therapeutics, Inc. (BTAI) | Chief Executive Officer and President | $459,000 | $1,968,931 |
| 2018 | BioXcel Therapeutics, Inc. (BTAI) | President and Chief Executive Officer | $423,359 | $701,609 |
Earnings-call appearances
-
Conference call to review topline data from the SERENITY At-Home Pivotal Phase 3 trial evaluating the safety of BXCL5012025-08-27
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-14
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-12
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-14
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-14
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-08
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-09
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-10
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-09
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-09
BioXcel Therapeutics, Inc. (BTAI)